CapsoVision Inc（CV）股票分析

$5.930

-0.127 (-2.15%)收盤時

Loading chart…

High: 6.284
Open: 6.130
VWAP: 6.05
Vol: 83.05K
Mkt Cap: —
Low: 5.930
Amount: 502.27K
EV/EBITDA, TTM: -7.28

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

www.capsovision.com

AI analysis of CapsoVision Inc (CV)

buy

CapsoVision Inc is a good buy right now, trading at $5.93 with a forward P/E of 0 and a gross margin of 51.36%. The recent 10% revenue growth in Q2 2026 and the positive analyst ratings suggest strong potential for recovery and growth. However, the main risk is the net income loss of $7.48 million in Q2 2026, which indicates ongoing financial challenges.

估值指標

The current forward P/E ratio for CapsoVision Inc (CV) is 0.00, compared to its 5-year average forward P/E of -10.86.

Forward P/E

Overvalued

5Y Average P/E

-10.86

Current P/E

0.00

高估

-5.23

低估

-16.50

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-6.21

Current EV/EBITDA

-7.28

高估

-0.77

低估

-11.64

Forward P/S

Fair

5Y Average P/S

12.96

Current P/S

15.36

高估

20.01

低估

5.91

Alphio AI Price Scenarios for CV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%CV

$5.79

情境價格

Base

Base · 50%CV

$5.05

情境價格

Bear

Bear · 25%CV

$4.89

情境價格

事件時間軸

2026-08-27 (ET)